Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,173.91
(
0.12%
)
US TECH 100
26,569.20
(
0.00%
)
Dow Jones
49,310.32
(
0.00%
)
Brent Oil
103.83
(
1.68%
)
Bitcoin
76,600.32
(
-1.00%
)
News Focus
News Focus
Post# of 347009
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biopharm

Send PM Follow Ignore
Followers 84
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

biopharm

Re: Dragon Lady post# 280848

Friday, 12/09/2016 4:31:51 PM

Friday, December 09, 2016 4:31:51 PM

Post# of 347009
Great job but I think an email will go out for the next phase. Can't argue with the science. Can't argue with the top docs all on board. You can't argue with new blood tests. You can't argue that PS Targeting .... The price hits $5 and that is when it all changes

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote